PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
2,615,737
Share change
-271,630
Total reported value
$23,832,480
Price per share
$9.11
Number of holders
39
Value change
-$2,615,686
Number of buys
13
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q3 2019

As of 30 Sep 2019, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,615,737 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, KENNEDY CAPITAL MANAGEMENT, INC., Tieton Capital Management, LLC, CRAWFORD INVESTMENT COUNSEL INC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., North Star Investment Management Corp., RBF Capital, LLC, and BLAIR WILLIAM & CO/IL. This page lists 39 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.